HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria pill could help control cholesterol
Disease control Recruiting nowThis study tests whether a daily probiotic called AKM Lab-01 can safely lower cholesterol levels in people with high cholesterol. About 60 adults aged 40-60 will take either the probiotic or a placebo for a period, and researchers will compare changes in blood fats, blood sugar, …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: NA • Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
CRISPR injection targets stubborn high cholesterol in first human trial
Disease control Recruiting nowThis early-phase study tests a single-dose CRISPR treatment (CTX310) designed to edit a gene that controls fat levels in the blood. It is for adults aged 18 to 75 with severe high cholesterol or triglycerides that do not improve with standard medications. The main goal is to chec…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New shot may slash 'Bad' cholesterol after heart attacks
Disease control Recruiting nowThis study tests whether adding a drug called inclisiran to standard care can lower 'bad' LDL cholesterol more than standard care alone in people who have recently had a heart attack, stroke, or urgent heart procedure. About 520 adults will be randomly assigned to receive either …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Italian registry to track Real-World use of cholesterol drug
Knowledge-focused Recruiting nowThis study is a registry that will follow 1,500 Italian adults taking alirocumab 300 mg for high cholesterol. Researchers want to see how well patients stick with the treatment over time and how much it lowers their LDL (bad) cholesterol in everyday life. The study does not test …
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC